Sesssion 1: Welcome and Opening
23 September 2026
Opening remarks and Candlelight Tribute
Yehia Omar
Sze Ting
Egyptian Atomic Energy Authority
IAEA Address
Diana Paez
WFNMB Address
Savvas Frangos
Ajit Padhy memorial lecture
Richard Baum
coffee break
10:30AM - 11:00AM
Session 2: Prostate Cancer 1: The PSMA landscape trials and new compounds in Prostate cancer
23 September 2026
PSMA Across the Prostate Cancer Journey: From Imaging to Treatment Guidance
Jeremie Calais
Radioligand therapy today: efficacy Proven, but at what cost in earlier settings?
Oliver Sartor
Expanding Access to PSMA Theranostics: Are There Affordable Alternatives?
Mike Sathekge
Improving RLT: From Fixed Paradigms to Smarter Strategies
Aviral Singh
Panel Discussion
Lunch break
1:00PM - 2:00PM
Sesssion 3: Next-generation rlt: can new isotopes redefine the treatment paradigm?
23 September 2026
Precision Theranostics with Tb-161: From Prostate to Pan-cancer
Swagat Dash
From Access to Outcomes: The Real-World KwaZulu-Natal Experience with Ac-225 PSMA
Mariza Vorster
225Ac monotherapy vs. 177Lu/225Ac tandem PSMA-RLT
Fadi Khreish
Astatine-211: A New Direction in PSMA-Targeted Alpha Therapy
Tadashi Watabe
Multidisciplinary Tumor Board: Case discussions
Coffee break
3:30PM - 04:00PM
Session 4: Navigating Global Challenges: Country-Specific Bottlenecks and Solutions
23 September 2026
10-minute immersive journey showcasing theranostics challenges at home
Yasmine Atteya
Batool Albalooshi
Mariela Agolti
Patricia Bautista
Swagat Dash
Mike Sathekge